Source link : https://newshealth.biz/health-news/fda-approves-label-change-for-alzheimers-amyloid-drug/
(MedPage Today) — The FDA approved a label update with a new titration schedule for donanemab (Kisunla), an anti-amyloid drug approved to treat early symptomatic Alzheimer’s disease, drugmaker Eli Lilly said. The move was designed to reduce the… Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/116438 Author : Publish date : 2025-07-09 21:08:00 Copyright for syndicated content belongs to […]
The post FDA Approves Label Change for Alzheimer’s Amyloid Drug first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-09 21:08:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8